{"id":20539,"date":"2022-06-14T04:00:00","date_gmt":"2022-06-14T10:00:00","guid":{"rendered":"https:\/\/canadianglycomics.ca\/?p=20539"},"modified":"2022-12-06T22:10:16","modified_gmt":"2022-12-07T05:10:16","slug":"glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen","status":"publish","type":"post","link":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/","title":{"rendered":"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"20539\" class=\"elementor elementor-20539\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-71709c09 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"71709c09\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-42674bfd\" data-id=\"42674bfd\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-37ae5336 elementor-widget elementor-widget-image\" data-id=\"37ae5336\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/canadianglycomics.ca\/fr\/\">\n\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/2019\/03\/Glyconet-Logo-300x104.png\" title=\"Glyconet-Logo-300\u00d7104\" alt=\"Glyconet-Logo-300x104\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-42da2325\" data-id=\"42da2325\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-39d16a9f elementor-shape-circle e-grid-align-right elementor-grid-0 elementor-widget elementor-widget-social-icons\" data-id=\"39d16a9f\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;none&quot;}\" data-widget_type=\"social-icons.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-social-icons-wrapper elementor-grid\" role=\"list\">\n\t\t\t\t\t\t\t<span class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t<a class=\"elementor-icon elementor-social-icon elementor-social-icon-linkedin-in elementor-repeater-item-8c6dfe2\" href=\"https:\/\/www.linkedin.com\/company\/glyconet\/?trk=biz-companies-cym\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-screen-only\">Linkedin-in<\/span>\n\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"fab fa-linkedin-in\"><\/i>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<span class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t<a class=\"elementor-icon elementor-social-icon elementor-social-icon-twitter elementor-repeater-item-3e2cd86\" href=\"https:\/\/twitter.com\/glyconet_nce\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-screen-only\">Twitter<\/span>\n\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"fab fa-twitter\"><\/i>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<span class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t<a class=\"elementor-icon elementor-social-icon elementor-social-icon-facebook-f elementor-repeater-item-bd500a1\" href=\"https:\/\/www.facebook.com\/glyconet\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-screen-only\">Facebook-f<\/span>\n\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"fab fa-facebook-f\"><\/i>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<span class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t<a class=\"elementor-icon elementor-social-icon elementor-social-icon-instagram elementor-repeater-item-8963384\" href=\"https:\/\/www.instagram.com\/glyconet_nce\/\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-screen-only\">Instagram<\/span>\n\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"fab fa-instagram\"><\/i>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<span class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t<a class=\"elementor-icon elementor-social-icon elementor-social-icon-youtube elementor-repeater-item-10f9273\" href=\"https:\/\/www.youtube.com\/channel\/UC-pj074TiGmzzpb_HzSl9ag\/feed\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-screen-only\">Youtube<\/span>\n\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"fab fa-youtube\"><\/i>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<span class=\"elementor-grid-item\" role=\"listitem\">\n\t\t\t\t\t<a class=\"elementor-icon elementor-social-icon elementor-social-icon-envelope elementor-repeater-item-5ba1b1f\" href=\"mailto:glyconet@ualberta.ca\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-screen-only\">Envelope<\/span>\n\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-envelope\"><\/i>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-77a42db elementor-section-height-min-height elementor-section-content-middle elementor-section-boxed elementor-section-height-default elementor-section-items-middle\" data-id=\"77a42db\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-no\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5860bd1d\" data-id=\"5860bd1d\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4abe765 uael-nav-menu__align-right uael-submenu-icon-classic uael-submenu-open-hover uael-submenu-animation-none uael-link-redirect-child uael-nav-menu__breakpoint-tablet uael-nav-menu-toggle-label-no elementor-widget elementor-widget-uael-nav-menu\" data-id=\"4abe765\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;distance_from_menu&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:0,&quot;sizes&quot;:[]},&quot;distance_from_menu_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;distance_from_menu_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]}}\" data-widget_type=\"uael-nav-menu.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"uael-nav-menu uael-layout-horizontal uael-nav-menu-layout uael-pointer__none\" data-layout=\"horizontal\">\n\t\t\t\t<div role=\"button\" class=\"uael-nav-menu__toggle elementor-clickable\">\n\t\t\t\t\t<span class=\"screen-reader-text\">Menu Principal<\/span>\n\t\t\t\t\t<div class=\"uael-nav-menu-icon\">\n\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-align-justify\"><\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<nav class=\"uael-nav-menu__layout-horizontal uael-nav-menu__submenu-classic\" data-toggle-icon=\"&lt;i aria-hidden=&quot;true&quot; class=&quot;fas fa-align-justify&quot;&gt;&lt;\/i&gt;\" data-close-icon=\"&lt;i aria-hidden=&quot;true&quot; class=&quot;far fa-window-close&quot;&gt;&lt;\/i&gt;\" data-full-width=\"yes\"><ul id=\"menu-1-4abe765\" class=\"uael-nav-menu\"><li id=\"menu-item-10673\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children parent uael-has-submenu uael-creative-menu\"><div class=\"uael-has-submenu-container\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/\" class = \"uael-menu-item\">\u00c0 propos<span class='uael-menu-toggle sub-arrow uael-menu-child-0'><i class='fa'><\/i><\/span><\/a><\/div>\n<ul class=\"sub-menu\">\n\t<li id=\"menu-item-13512\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/\" class = \"uael-sub-menu-item\">\u00c0 propos de GlycoNet<\/a><\/li>\n\t<li id=\"menu-item-18203\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/people\/\" class = \"uael-sub-menu-item\">Qui nous sommes<\/a><\/li>\n\t<li id=\"menu-item-10674\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/administration\/\" class = \"uael-sub-menu-item\">Administration<\/a><\/li>\n\t<li id=\"menu-item-10680\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/glyconets-corporate-policies\/\" class = \"uael-sub-menu-item\">Politiques d\u2019entreprise<\/a><\/li>\n\t<li id=\"menu-item-13545\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children uael-has-submenu uael-creative-menu\"><div class=\"uael-has-submenu-container\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/governance\/\" class = \"uael-sub-menu-item\">Gouvernance<span class='uael-menu-toggle sub-arrow uael-menu-child-1'><i class='fa'><\/i><\/span><\/a><\/div>\n\t<ul class=\"sub-menu\">\n\t\t<li id=\"menu-item-13702\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/governance\/board-of-directors\/\" class = \"uael-sub-menu-item\">Conseil d'Administration<\/a><\/li>\n\t\t<li id=\"menu-item-13697\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/governance\/executive-committee\/\" class = \"uael-sub-menu-item\">Comit\u00e9 Ex\u00e9cutif<\/a><\/li>\n\t\t<li id=\"menu-item-13696\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/governance\/finance-and-audit-committee\/\" class = \"uael-sub-menu-item\">Comit\u00e9 des Finances, de l'Audit et de la Gestion des Risques<\/a><\/li>\n\t\t<li id=\"menu-item-13695\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/governance\/nominating-committee\/\" class = \"uael-sub-menu-item\">Comit\u00e9 de Nomination et de Gouvernance<\/a><\/li>\n\t\t<li id=\"menu-item-13701\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/governance\/research-management-committee\/\" class = \"uael-sub-menu-item\">Comit\u00e9 de Gestion de la Recherche<\/a><\/li>\n\t\t<li id=\"menu-item-13700\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/governance\/scientific-advisory-board\/\" class = \"uael-sub-menu-item\">Conseil Consultatif Scientifique<\/a><\/li>\n\t\t<li id=\"menu-item-13699\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/governance\/commercialization-legacy-committee\/\" class = \"uael-sub-menu-item\">Comit\u00e9 de Commercialisation<\/a><\/li>\n\t\t<li id=\"menu-item-13698\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/governance\/equity-diversity-and-inclusion-committee\/\" class = \"uael-sub-menu-item\">Comit\u00e9 pour l\u2019\u00c9quit\u00e9, la Diversit\u00e9 et l\u2019Inclusion<\/a><\/li>\n\t\t<li id=\"menu-item-27267\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/governance\/steering-and-advisory-committee\/\" class = \"uael-sub-menu-item\">GIS Steering and Advisory Committee<\/a><\/li>\n\t\t<li id=\"menu-item-13703\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/governance\/training-committee\/\" class = \"uael-sub-menu-item\">Comit\u00e9 de Formation<\/a><\/li>\n\t<\/ul>\n<\/li>\n\t<li id=\"menu-item-21453\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children uael-has-submenu uael-creative-menu\"><div class=\"uael-has-submenu-container\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/edi\/\" class = \"uael-sub-menu-item\">\u00c9quit\u00e9, diversit\u00e9 et inclusion<span class='uael-menu-toggle sub-arrow uael-menu-child-1'><i class='fa'><\/i><\/span><\/a><\/div>\n\t<ul class=\"sub-menu\">\n\t\t<li id=\"menu-item-25363\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/edi\/loop\/\" class = \"uael-sub-menu-item\">LOOP<\/a><\/li>\n\t<\/ul>\n<\/li>\n\t<li id=\"menu-item-10681\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/partners\/\" class = \"uael-sub-menu-item\">Partenaires<\/a><\/li>\n\t<li id=\"menu-item-10682\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/about\/become-a-member\/\" class = \"uael-sub-menu-item\">Devenir Membre<\/a><\/li>\n\t<li id=\"menu-item-10700\" class=\"menu-item menu-item-type-custom menu-item-object-custom menu-item-has-children uael-has-submenu uael-creative-menu\"><div class=\"uael-has-submenu-container\"><a href=\"https:\/\/forum.glyconet.ca\/index.php\/Main_Page\" class = \"uael-sub-menu-item\">Forum<span class='uael-menu-toggle sub-arrow uael-menu-child-1'><i class='fa'><\/i><\/span><\/a><\/div>\n\t<ul class=\"sub-menu\">\n\t\t<li id=\"menu-item-13816\" class=\"menu-item menu-item-type-custom menu-item-object-custom uael-creative-menu\"><a href=\"https:\/\/forum.glyconet.ca\/index.php\/Main_Page\" class = \"uael-sub-menu-item\">Forum de GlycoNet<\/a><\/li>\n\t\t<li id=\"menu-item-10670\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/forum-help-and-faqs\/\" class = \"uael-sub-menu-item\">Aide pour le Forum et FAQ<\/a><\/li>\n\t<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<li id=\"menu-item-10676\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children parent uael-has-submenu uael-creative-menu\"><div class=\"uael-has-submenu-container\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/research\/\" class = \"uael-menu-item\">Recherche<span class='uael-menu-toggle sub-arrow uael-menu-child-0'><i class='fa'><\/i><\/span><\/a><\/div>\n<ul class=\"sub-menu\">\n\t<li id=\"menu-item-14137\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/research\/\" class = \"uael-sub-menu-item\">Th\u00e8mes de recherche<\/a><\/li>\n\t<li id=\"menu-item-26134\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/research\/research-security\/\" class = \"uael-sub-menu-item\">Research Security<\/a><\/li>\n\t<li id=\"menu-item-17905\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/technology-highlights\/\" class = \"uael-sub-menu-item\">Points Forts de la Technologie<\/a><\/li>\n\t<li id=\"menu-item-10684\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/research\/glyco-backgrounder\/\" class = \"uael-sub-menu-item\">introduction \u00e0 la glycomique<\/a><\/li>\n\t<li id=\"menu-item-10685\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/research\/call-for-proposals\/\" class = \"uael-sub-menu-item\">Appel \u00e0  propositions<\/a><\/li>\n\t<li id=\"menu-item-23739\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/research\/research-activities-costs\/\" class = \"uael-sub-menu-item\">Eligibilit\u00e9 aux Activit\u00e9s de Recherche et aux Frais Associ\u00e9s.<\/a><\/li>\n\t<li id=\"menu-item-10688\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/research\/projects\/\" class = \"uael-sub-menu-item\">Projets<\/a><\/li>\n<\/ul>\n<\/li>\n<li id=\"menu-item-19047\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children parent uael-has-submenu uael-creative-menu\"><div class=\"uael-has-submenu-container\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/services\/\" class = \"uael-menu-item\">Services<span class='uael-menu-toggle sub-arrow uael-menu-child-0'><i class='fa'><\/i><\/span><\/a><\/div>\n<ul class=\"sub-menu\">\n\t<li id=\"menu-item-25494\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/services\/\" class = \"uael-sub-menu-item\">Services int\u00e9gr\u00e9s<\/a><\/li>\n\t<li id=\"menu-item-19048\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/services\/accessing-the-facility-plus\/\" class = \"uael-sub-menu-item\">Acc\u00e9der au centre<\/a><\/li>\n\t<li id=\"menu-item-19050\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/services\/equipment-and-services-plus\/\" class = \"uael-sub-menu-item\">\u00c9quipements et services<\/a><\/li>\n\t<li id=\"menu-item-19049\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/services\/request-services-plus\/\" class = \"uael-sub-menu-item\">Demande de services<\/a><\/li>\n<\/ul>\n<\/li>\n<li id=\"menu-item-10672\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children parent uael-has-submenu uael-creative-menu\"><div class=\"uael-has-submenu-container\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/\" class = \"uael-menu-item\">Ressources &amp; Formation<span class='uael-menu-toggle sub-arrow uael-menu-child-0'><i class='fa'><\/i><\/span><\/a><\/div>\n<ul class=\"sub-menu\">\n\t<li id=\"menu-item-13813\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children uael-has-submenu uael-creative-menu\"><div class=\"uael-has-submenu-container\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/\" class = \"uael-sub-menu-item\">Programme de Formation<span class='uael-menu-toggle sub-arrow uael-menu-child-1'><i class='fa'><\/i><\/span><\/a><\/div>\n\t<ul class=\"sub-menu\">\n\t\t<li id=\"menu-item-28058\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/internships-exchanges-awards\/summer-awards-for-undergraduate-students\/\" class = \"uael-sub-menu-item\">Bourses d'\u00e9t\u00e9 pour \u00e9tudiants de premier cycle<\/a><\/li>\n\t\t<li id=\"menu-item-28057\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/internships-exchanges-awards\/advanced-training-opportunity-program\/\" class = \"uael-sub-menu-item\">Programme d'opportunit\u00e9s de formation avanc\u00e9e<\/a><\/li>\n\t<\/ul>\n<\/li>\n\t<li id=\"menu-item-10692\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children uael-has-submenu uael-creative-menu\"><div class=\"uael-has-submenu-container\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/trainee-association\/\" class = \"uael-sub-menu-item\">Association des Stagiaires<span class='uael-menu-toggle sub-arrow uael-menu-child-1'><i class='fa'><\/i><\/span><\/a><\/div>\n\t<ul class=\"sub-menu\">\n\t\t<li id=\"menu-item-29608\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/application\/\" class = \"uael-sub-menu-item\">Call for members for GTA Executive Committee<\/a><\/li>\n\t<\/ul>\n<\/li>\n\t<li id=\"menu-item-10691\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children uael-has-submenu uael-creative-menu\"><div class=\"uael-has-submenu-container\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/internships-exchanges-awards\/\" class = \"uael-sub-menu-item\">Stages, Programmes d\u2019\u00c9change &amp; Bourses<span class='uael-menu-toggle sub-arrow uael-menu-child-1'><i class='fa'><\/i><\/span><\/a><\/div>\n\t<ul class=\"sub-menu\">\n\t\t<li id=\"menu-item-13936\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/internships-exchanges-awards\/mitacs-internship\/\" class = \"uael-sub-menu-item\">Stage Mitacs<\/a><\/li>\n\t\t<li id=\"menu-item-16960\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/internships-exchanges-awards\/technical-skills-fundamentals-training-program\/\" class = \"uael-sub-menu-item\">Programme de formation sur les comp\u00e9tences techniques fondamentales<\/a><\/li>\n\t<\/ul>\n<\/li>\n\t<li id=\"menu-item-10693\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/opportunities\/\" class = \"uael-sub-menu-item\">Opportunit\u00e9s d\u2019Emploi<\/a><\/li>\n\t<li id=\"menu-item-13814\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children uael-has-submenu uael-creative-menu\"><div class=\"uael-has-submenu-container\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/glycomics-resources\/\" class = \"uael-sub-menu-item\">Ressources<span class='uael-menu-toggle sub-arrow uael-menu-child-1'><i class='fa'><\/i><\/span><\/a><\/div>\n\t<ul class=\"sub-menu\">\n\t\t<li id=\"menu-item-12587\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/glycomics-resources\/\" class = \"uael-sub-menu-item\">Ressources en Glycomique<\/a><\/li>\n\t\t<li id=\"menu-item-20104\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/vaccines-and-hesitancy\/\" class = \"uael-sub-menu-item\">Ressources p\u00e9dagogiques sur les vaccins et la r\u00e9ticence<\/a><\/li>\n\t\t<li id=\"menu-item-12655\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/high-school-resources\/\" class = \"uael-sub-menu-item\">Ressources pour l\u2019\u00e9cole Secondaire<\/a><\/li>\n\t<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<li id=\"menu-item-10671\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children parent uael-has-submenu uael-creative-menu\"><div class=\"uael-has-submenu-container\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/news-events\/\" class = \"uael-menu-item\">Nouvelles &amp; \u00c9v\u00e8nements<span class='uael-menu-toggle sub-arrow uael-menu-child-0'><i class='fa'><\/i><\/span><\/a><\/div>\n<ul class=\"sub-menu\">\n\t<li id=\"menu-item-13815\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/news-events\/\" class = \"uael-sub-menu-item\">Nouvelles<\/a><\/li>\n\t<li id=\"menu-item-10695\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/curioseity\/\" class = \"uael-sub-menu-item\">Le Blog CuriOSEity<\/a><\/li>\n\t<li id=\"menu-item-13365\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/training\/webinar-series\/\" class = \"uael-sub-menu-item\">S\u00e9rie de webinaires<\/a><\/li>\n\t<li id=\"menu-item-10694\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/news-events\/annual-reports\/\" class = \"uael-sub-menu-item\">Rapports Annuels<\/a><\/li>\n\t<li id=\"menu-item-10697\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/news-events\/newsletters\/\" class = \"uael-sub-menu-item\">Bulletins d\u2019information<\/a><\/li>\n\t<li id=\"menu-item-11049\" class=\"menu-item menu-item-type-custom menu-item-object-custom uael-creative-menu\"><a href=\"http:\/\/www.symposium.canadianglycomics.ca\/\" class = \"uael-sub-menu-item\">Symposium Canadien sur la Glycomique<\/a><\/li>\n\t<li id=\"menu-item-10696\" class=\"menu-item menu-item-type-post_type menu-item-object-page uael-creative-menu\"><a href=\"https:\/\/canadianglycomics.ca\/fr\/news-events\/media-room\/\" class = \"uael-sub-menu-item\">Salle des m\u00e9dias<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul><\/nav>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-37492806 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"37492806\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-540ab0ae\" data-id=\"540ab0ae\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-fb1612e elementor-widget elementor-widget-spacer\" data-id=\"fb1612e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3d05a3f elementor-widget elementor-widget-image\" data-id=\"3d05a3f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"96\" src=\"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/glyconet-logo-300x96.png\" class=\"attachment-medium size-medium wp-image-13746\" alt=\"\" srcset=\"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/glyconet-logo-300x96.png 300w, https:\/\/canadianglycomics.ca\/wp-content\/uploads\/glyconet-logo-768x245.png 768w, https:\/\/canadianglycomics.ca\/wp-content\/uploads\/glyconet-logo.png 1004w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-00467f7 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"00467f7\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-4c66e01\" data-id=\"4c66e01\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ec009c9 elementor-widget elementor-widget-text-editor\" data-id=\"ec009c9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"text-align: left;\">Pour publication imm\u00e9diate<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<div class=\"elementor-element elementor-element-3fd83ac7 elementor-widget elementor-widget-text-editor\" data-id=\"3fd83ac7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2 class=\"article-headline\" style=\"text-align: center;\">GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen<\/h2>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3b3699e8 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"3b3699e8\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-628e0f80\" data-id=\"628e0f80\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-74c664c elementor-widget elementor-widget-text-editor\" data-id=\"74c664c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h6 style=\"text-align: center;\">This collaboration combines Alectos\u2019 expertise in small-molecule therapeutics with Biogen\u2019s development capabilities in movement disorders.<\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-889a713 elementor-widget elementor-widget-image\" data-id=\"889a713\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"768\" height=\"576\" src=\"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Parkinsons-Disease-min-1-768x576.png\" class=\"attachment-medium_large size-medium_large wp-image-21718\" alt=\"\" srcset=\"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Parkinsons-Disease-min-1-768x576.png 768w, https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Parkinsons-Disease-min-1-300x225.png 300w, https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Parkinsons-Disease-min-1-1024x768.png 1024w, https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Parkinsons-Disease-min-1-16x12.png 16w, https:\/\/canadianglycomics.ca\/wp-content\/uploads\/Parkinsons-Disease-min-1.png 1200w\" sizes=\"(max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4a439362 elementor-widget elementor-widget-text-editor\" data-id=\"4a439362\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>EDMONTON, June 14, 2022<\/strong> \u2013 GlycoNet, one of the world\u2019s leaders in glycomics \u2013 the study of carbohydrates in all living organisms \u2013 is pleased to announce that their partner company, Alectos Therapeutics has entered into a <a href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/06\/06\/2456602\/0\/en\/Biogen-and-Alectos-Therapeutics-Announce-License-and-Collaboration-Agreement-for-AL01811-a-Novel-GBA2-Inhibitor-for-the-Potential-Treatment-of-Parkinson-s-Disease.html\">$700 million licensing and collaboration agreement<\/a> with Biogen. This partnership will advance research critical to improving the quality of life for patients with Parkinson\u2019s disease. Affecting 1 in 500 Canadians, Parkinson\u2019s is the fastest-growing neurological disease in the world and a leading cause of disability<sup>1<\/sup>.<\/p><p>This recently announced partnership<sup>2<\/sup> aims to develop and commercialize a novel preclinical selective GBA2 inhibitor, AL01811, which has first-in-class potential as an oral medicine to prevent the progression of Parkinson\u2019s. This collaboration combines Alectos\u2019 expertise in small-molecule therapeutics with Biogen\u2019s development capabilities in movement disorders.<\/p><p>Alectos\u2019 primary focus has been in the space of glycomics, small molecule inhibitors directed towards carbohydrate processing enzymes for neurodegenerative diseases, and neuroscience which has allowed the development of novel therapeutic strategies to address these diseases.<\/p><p>\u201cWe\u2019ve been strong supporters of GlycoNet for a number of years. The productive and effective collaboration between GlycoNet researchers and industry, of which we are a part of, is really an important cornerstone of drug discovery and the Canadian healthcare ecosystem,\u201d says Ernest McEachern, Ph.D., President and CEO, Alectos. \u201cThere are many glycomics discoveries that lead to important healthcare breakthroughs which originate in academic labs and through academic collaborations thanks to the grant funding and support of GlycoNet.\u201d<\/p><p>\u201cThe $700M partnership between Alectos and Biogen for the development of a new drug for Parkinson&#8217;s is another example of the tremendous and proven health and economic impact of glycomics research and innovation in Canada,\u201d says Elizabeth Nanak, CEO, GlycoNet.<\/p><p>Glycomics offers unique and progressive ways to monitor and modulate biological processes in all living organisms. This largely untapped scientific potential is at the centre of a new surge of development, with breakthrough discoveries helping to treat some of the world\u2019s most common and rare diseases, including Parkinson\u2019s.<\/p><p><strong>About Alectos Therapeutics<\/strong><br \/>Alectos Therapeutics is a leader in the discovery and preclinical development of novel small-molecule therapeutics to treat neurological diseases. Alectos focuses on identifying and developing innovative disease modifying strategies to address complex neurological conditions for which there are no effective treatments, including Alzheimer\u2019s disease and Parkinson\u2019s disease. Alectos plans to leverage its Biogen partnership to advance its pipeline of preclinical glycomics assets, including O-GlcNAcase inhibitors for dementia and ischemic stroke. For more information, please visit <a href=\"https:\/\/www.alectos.com\/\">www.alectos.com<\/a> and follow Alectos on social media &#8211; <a href=\"https:\/\/twitter.com\/alectostx\">Twitter<\/a>, <a href=\"https:\/\/www.linkedin.com\/company\/alectos-therapeutics-inc\/\">LinkedIn<\/a>.<\/p><p><strong>\u00c0 propos de GlycoNet<br \/><\/strong>GlycoNet is advancing research, innovation and training in glycomics to improve the quality of life of Canadians. GlycoNet is a one-stop global destination focused on developing new carbohydrate-based drugs, vaccines and diagnostics, in collaboration with academic and industry organizations to address areas of unmet need through applied glycomics research. Funded by the federal Networks of Centres of Excellence (NCE) program and a range of partners, the network includes over 180 researchers across Canada who focus on cancer, chronic diseases, infectious diseases and neurodegenerative diseases. This national platform supports translational research, protection of intellectual property, novel drug development, company formation and training. Learn more about us at <a href=\"https:\/\/canadianglycomics.ca\/fr\/\">glyconet.ca<\/a>.<\/p><p>More information on the potential of Canadian glycomics can be found at: <a href=\"https:\/\/canadianglycomics.ca\/fr\/op-ed-glycomics-are-the-new-frontier-in-bioinnovation\/\">https:\/\/canadianglycomics.ca\/op-ed-glycomics-are-the-new-frontier-in-bioinnovation\/<\/a><\/p><p><strong>Contact GlycoNet<br \/><\/strong>Swati Mehta<br \/>Account Director, PR Associates<br \/><a href=\"mailto:smehta@prassociates.com\" target=\"_blank\" rel=\"noopener\">smehta@prassociates.com<\/a><br \/>403-804-0768<\/p><p><sup>1<\/sup><a href=\"https:\/\/www.michaeljfox.org\/sites\/default\/files\/media\/document\/2019%20Parkinson%27s%20Economic%20Burden%20Study%20-%20FINAL.pdf\">https:\/\/www.michaeljfox.org\/sites\/default\/files\/media\/document\/2019%20Parkinson%27s%20Economic%20Burden%20Study%20-%20FINAL.pdf<\/a><br \/><sup>2<\/sup><a href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/06\/06\/2456602\/0\/en\/Biogen-and-Alectos-Therapeutics-Announce-License-and-Collaboration-Agreement-for-AL01811-a-Novel-GBA2-Inhibitor-for-the-Potential-Treatment-of-Parkinson-s-Disease.html\">https:\/\/www.globenewswire.com\/news-release\/2022\/06\/06\/2456602\/0\/en\/Biogen-and-Alectos-Therapeutics-Announce-License-and-Collaboration-Agreement-for-AL01811-a-Novel-GBA2-Inhibitor-for-the-Potential-Treatment-of-Parkinson-s-Disease.html<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5622578f elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"5622578f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ab855e9 elementor-widget elementor-widget-text-editor\" data-id=\"ab855e9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h6 style=\"text-align: center;\">Plus de <a href=\"http:\/\/canadianglycomics.ca\/fr\/news-events\/\">nouvelles de GlycoNet<\/a><\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-28f7876 elementor-widget elementor-widget-spacer\" data-id=\"28f7876\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7cf49d67 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7cf49d67\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-16 elementor-top-column elementor-element elementor-element-21be8d64\" data-id=\"21be8d64\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-55764c75 elementor-widget elementor-widget-text-editor\" data-id=\"55764c75\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/about\/\"><b>\u00c0 propos<\/b><\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/about\/administration\/\">Administration<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/about\/glyconets-corporate-policies\/\">Politiques d\u2019entreprise<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/about\/governance\/\">Gouvernance<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/about\/partners\/\">Partenaires<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/people\/\">Qui nous sommes<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/about\/become-a-member\/\">Devenir Membre<\/a><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-16 elementor-top-column elementor-element elementor-element-5869d817\" data-id=\"5869d817\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5f443596 elementor-widget elementor-widget-text-editor\" data-id=\"5f443596\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"https:\/\/canadianglycomics.ca\/fr\/research\/\"><b>Recherche<\/b><\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/research\/glyco-backgrounder\/\">introduction \u00e0 la glycomique<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/research\/call-for-proposals\/\">Appel \u00e0  propositions<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/research\/core-services\/\">Services Centraux<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/research\/projects\/\">Projets<\/a><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-16 elementor-top-column elementor-element elementor-element-42421025\" data-id=\"42421025\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-29e27079 elementor-widget elementor-widget-text-editor\" data-id=\"29e27079\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/training\/\"><b>Formation<\/b><\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/training\/webinar-series\/\">S\u00e9rie de webinaires<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/training\/trainee-association\/\">Association des Stagiaires<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/training\/internships-exchanges-awards\/\">Stages, \u00c9changes &amp; Bourses<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/training\/opportunities\/\">Opportunit\u00e9s d\u2019Emploi<\/a><\/span><br \/><span style=\"color: #ffffff;\">Ressources<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-16 elementor-top-column elementor-element elementor-element-6a29fa8d\" data-id=\"6a29fa8d\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-bf82773 elementor-widget elementor-widget-text-editor\" data-id=\"bf82773\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/news-events\/\"><b>Nouvelles &amp; \u00c9v\u00e8nements<\/b><\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/news-events\/annual-reports\/\">Rapports Annuels<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/curioseity\/\">CuriOSEity<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/news-events\/media-room\/\">Salle des m\u00e9dias<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/news-events\/newsletters\/\">Bulletins d\u2019information<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/symposium.canadianglycomics.ca\">Symposium Canadien sur la Glycomique<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/news-events\/upcoming-events\/\">\u00c9v\u00e8nements \u00e0 Venir<\/a><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-16 elementor-top-column elementor-element elementor-element-4a168a5c\" data-id=\"4a168a5c\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5065518 elementor-widget elementor-widget-text-editor\" data-id=\"5065518\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/contact\/\"><b>Contact<\/b><\/a><\/span><\/p><p><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"https:\/\/forum.glyconet.ca\/index.php\/Main_Page\"><b>Forum<\/b><\/a><\/span><br \/><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"http:\/\/canadianglycomics.ca\/fr\/forum-help-and-faqs\/\">Aide pour le Forum et FAQ<\/a><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-16 elementor-top-column elementor-element elementor-element-6249953e\" data-id=\"6249953e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5ae9fa24 elementor-widget elementor-widget-image\" data-id=\"5ae9fa24\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"297\" height=\"95\" src=\"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/GlycoNet_logo_landscape_white-1.png\" class=\"attachment-large size-large wp-image-11877\" alt=\"\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-59e9842c elementor-widget elementor-widget-text-editor\" data-id=\"59e9842c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>R\u00e9seau Canadien de la Glycomique<br \/>E5-33 Gunning\/Lemieux Chemistry Centre<br \/>University of Alberta, T6G 2G2<br \/>T\u00e9l.: 780-492-6204<br \/>T\u00e9l\u00e9c.: 780-492-4147<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-1e516ec7 elementor-section-content-middle elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1e516ec7\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-175949e4\" data-id=\"175949e4\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f8b71b6 elementor-widget elementor-widget-text-editor\" data-id=\"f8b71b6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\u00a9 R\u00e9seau Canadien de la Glycomique (GlycoNet). Tous droits r\u00e9serv\u00e9s.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>This collaboration combines Alectos\u2019 expertise in small-molecule therapeutics with Biogen\u2019s development capabilities in movement disorders.<\/p>","protected":false},"author":2,"featured_media":13746,"comment_status":"closed","ping_status":"open","sticky":false,"template":"elementor_canvas","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[200],"tags":[221,222,7,220],"class_list":["post-20539","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release","tag-alectos-therapeutics","tag-biogen","tag-glyconet","tag-parkinsons-disease","wpbf-post"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"This collaboration combines Alectos\u2019 expertise in small-molecule therapeutics with Biogen\u2019s development capabilities in movement disorders.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Canadian Glycomics Network\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_CA\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Canadian Glycomics Network - Improving the quality of life of Canadians through glycomics\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen - Canadian Glycomics Network\" \/>\n\t\t<meta property=\"og:description\" content=\"This collaboration combines Alectos\u2019 expertise in small-molecule therapeutics with Biogen\u2019s development capabilities in movement disorders.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/glyconet-logo.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/glyconet-logo.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1004\" \/>\n\t\t<meta property=\"og:image:height\" content=\"320\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2022-06-14T10:00:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2022-12-07T05:10:16+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen - Canadian Glycomics Network\" \/>\n\t\t<meta name=\"twitter:description\" content=\"This collaboration combines Alectos\u2019 expertise in small-molecule therapeutics with Biogen\u2019s development capabilities in movement disorders.\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/glyconet-logo.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\\\/#blogposting\",\"name\":\"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen - Canadian Glycomics Network\",\"headline\":\"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen\",\"author\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/author\\\/cgnadmin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/canadianglycomics.ca\\\/wp-content\\\/uploads\\\/glyconet-logo.png\",\"width\":1004,\"height\":320},\"datePublished\":\"2022-06-14T04:00:00-06:00\",\"dateModified\":\"2022-12-06T22:10:16-07:00\",\"inLanguage\":\"fr-CA\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\\\/#webpage\"},\"articleSection\":\"Press Release, Alectos Therapeutics, Biogen, GlycoNet, Parkinson&#039;s Disease\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/#listItem\",\"name\":\"Network News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/#listItem\",\"position\":2,\"name\":\"Network News\",\"item\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/press-release\\\/#listItem\",\"name\":\"Press Release\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/press-release\\\/#listItem\",\"position\":3,\"name\":\"Press Release\",\"item\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/press-release\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\\\/#listItem\",\"name\":\"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/#listItem\",\"name\":\"Network News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\\\/#listItem\",\"position\":4,\"name\":\"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/category\\\/network-news\\\/press-release\\\/#listItem\",\"name\":\"Press Release\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Glycomics Network\",\"description\":\"Improving the quality of life of Canadians through glycomics\",\"url\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/canadianglycomics.ca\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/Glyconet-Logo-300x104.png\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\\\/#organizationLogo\",\"width\":300,\"height\":104},\"image\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/author\\\/cgnadmin\\\/#author\",\"url\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/author\\\/cgnadmin\\\/\",\"name\":\"Canadian Glycomics Network\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a6385fd9f23cefa7d601a206cf492aa975e2d5dff33089294a1ec55f6199da4a?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Canadian Glycomics Network\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\\\/#webpage\",\"url\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\\\/\",\"name\":\"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen - Canadian Glycomics Network\",\"description\":\"This collaboration combines Alectos\\u2019 expertise in small-molecule therapeutics with Biogen\\u2019s development capabilities in movement disorders.\",\"inLanguage\":\"fr-CA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/author\\\/cgnadmin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/author\\\/cgnadmin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/canadianglycomics.ca\\\/wp-content\\\/uploads\\\/glyconet-logo.png\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\\\/#mainImage\",\"width\":1004,\"height\":320},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\\\/#mainImage\"},\"datePublished\":\"2022-06-14T04:00:00-06:00\",\"dateModified\":\"2022-12-06T22:10:16-07:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/\",\"name\":\"Canadian Glycomics Network\",\"description\":\"Improving the quality of life of Canadians through glycomics\",\"inLanguage\":\"fr-CA\",\"publisher\":{\"@id\":\"https:\\\/\\\/canadianglycomics.ca\\\/fr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen - Canadian Glycomics Network","description":"This collaboration combines Alectos\u2019 expertise in small-molecule therapeutics with Biogen\u2019s development capabilities in movement disorders.","canonical_url":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/#blogposting","name":"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen - Canadian Glycomics Network","headline":"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen","author":{"@id":"https:\/\/canadianglycomics.ca\/fr\/author\/cgnadmin\/#author"},"publisher":{"@id":"https:\/\/canadianglycomics.ca\/fr\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/glyconet-logo.png","width":1004,"height":320},"datePublished":"2022-06-14T04:00:00-06:00","dateModified":"2022-12-06T22:10:16-07:00","inLanguage":"fr-CA","mainEntityOfPage":{"@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/#webpage"},"isPartOf":{"@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/#webpage"},"articleSection":"Press Release, Alectos Therapeutics, Biogen, GlycoNet, Parkinson&#039;s Disease"},{"@type":"BreadcrumbList","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/#listItem","position":1,"name":"Home","item":"https:\/\/canadianglycomics.ca\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/#listItem","name":"Network News"}},{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/#listItem","position":2,"name":"Network News","item":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/press-release\/#listItem","name":"Press Release"},"previousItem":{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/press-release\/#listItem","position":3,"name":"Press Release","item":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/press-release\/","nextItem":{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/#listItem","name":"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen"},"previousItem":{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/#listItem","name":"Network News"}},{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/#listItem","position":4,"name":"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen","previousItem":{"@type":"ListItem","@id":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/press-release\/#listItem","name":"Press Release"}}]},{"@type":"Organization","@id":"https:\/\/canadianglycomics.ca\/fr\/#organization","name":"Canadian Glycomics Network","description":"Improving the quality of life of Canadians through glycomics","url":"https:\/\/canadianglycomics.ca\/fr\/","logo":{"@type":"ImageObject","url":"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/2019\/03\/Glyconet-Logo-300x104.png","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/#organizationLogo","width":300,"height":104},"image":{"@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/canadianglycomics.ca\/fr\/author\/cgnadmin\/#author","url":"https:\/\/canadianglycomics.ca\/fr\/author\/cgnadmin\/","name":"Canadian Glycomics Network","image":{"@type":"ImageObject","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/a6385fd9f23cefa7d601a206cf492aa975e2d5dff33089294a1ec55f6199da4a?s=96&d=mm&r=g","width":96,"height":96,"caption":"Canadian Glycomics Network"}},{"@type":"WebPage","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/#webpage","url":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/","name":"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen - Canadian Glycomics Network","description":"This collaboration combines Alectos\u2019 expertise in small-molecule therapeutics with Biogen\u2019s development capabilities in movement disorders.","inLanguage":"fr-CA","isPartOf":{"@id":"https:\/\/canadianglycomics.ca\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/#breadcrumblist"},"author":{"@id":"https:\/\/canadianglycomics.ca\/fr\/author\/cgnadmin\/#author"},"creator":{"@id":"https:\/\/canadianglycomics.ca\/fr\/author\/cgnadmin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/glyconet-logo.png","@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/#mainImage","width":1004,"height":320},"primaryImageOfPage":{"@id":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/#mainImage"},"datePublished":"2022-06-14T04:00:00-06:00","dateModified":"2022-12-06T22:10:16-07:00"},{"@type":"WebSite","@id":"https:\/\/canadianglycomics.ca\/fr\/#website","url":"https:\/\/canadianglycomics.ca\/fr\/","name":"Canadian Glycomics Network","description":"Improving the quality of life of Canadians through glycomics","inLanguage":"fr-CA","publisher":{"@id":"https:\/\/canadianglycomics.ca\/fr\/#organization"}}]},"og:locale":"fr_CA","og:site_name":"Canadian Glycomics Network - Improving the quality of life of Canadians through glycomics","og:type":"article","og:title":"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen - Canadian Glycomics Network","og:description":"This collaboration combines Alectos\u2019 expertise in small-molecule therapeutics with Biogen\u2019s development capabilities in movement disorders.","og:url":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/","og:image":"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/glyconet-logo.png","og:image:secure_url":"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/glyconet-logo.png","og:image:width":1004,"og:image:height":320,"article:published_time":"2022-06-14T10:00:00+00:00","article:modified_time":"2022-12-07T05:10:16+00:00","twitter:card":"summary_large_image","twitter:title":"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen - Canadian Glycomics Network","twitter:description":"This collaboration combines Alectos\u2019 expertise in small-molecule therapeutics with Biogen\u2019s development capabilities in movement disorders.","twitter:image":"https:\/\/canadianglycomics.ca\/wp-content\/uploads\/glyconet-logo.png"},"aioseo_meta_data":{"post_id":"20539","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-05-29 19:11:19","updated":"2025-06-04 03:51:08","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/canadianglycomics.ca\/fr\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/\" title=\"Network News\">Network News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/press-release\/\" title=\"Press Release\">Press Release<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tGlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/canadianglycomics.ca\/fr\/"},{"label":"Network News","link":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/"},{"label":"Press Release","link":"https:\/\/canadianglycomics.ca\/fr\/category\/network-news\/press-release\/"},{"label":"GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen","link":"https:\/\/canadianglycomics.ca\/fr\/glyconet-partner-company-alectos-therapeutics-enters-ground-breaking-700-million-agreement-with-biogen\/"}],"_links":{"self":[{"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/posts\/20539","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/comments?post=20539"}],"version-history":[{"count":21,"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/posts\/20539\/revisions"}],"predecessor-version":[{"id":21721,"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/posts\/20539\/revisions\/21721"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/media\/13746"}],"wp:attachment":[{"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/media?parent=20539"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/categories?post=20539"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianglycomics.ca\/fr\/wp-json\/wp\/v2\/tags?post=20539"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}